These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6892345)
41. [The ultrastructure of bovine lymphocytes in chronic lymphocytic leucosis]. Hajdu I; Cerný L Cesk Patol; 1976 Aug; 12(3):136-40. PubMed ID: 1030333 [TBL] [Abstract][Full Text] [Related]
42. Thymidine transport in human lymphocytes stimulated with concanavalin A: effect of colchicine. Rudd CE; Kaplan JG J Immunol; 1981 Apr; 126(4):1640-3. PubMed ID: 7204981 [TBL] [Abstract][Full Text] [Related]
43. The effect of microtubule- and microfilament-disrupting drugs on preimplantation mouse embryos. Siracusa G; Whittingham DG; De Felici M J Embryol Exp Morphol; 1980 Dec; 60():71-82. PubMed ID: 7198136 [TBL] [Abstract][Full Text] [Related]
44. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells. Moon EY; Lerner A Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529 [TBL] [Abstract][Full Text] [Related]
45. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237 [TBL] [Abstract][Full Text] [Related]
46. [Programmed death of cells (apoptosis)]. Gorczyca W; Melamed MR; Darzynkiewicz Z Patol Pol; 1993; 44(3):113-9. PubMed ID: 8247638 [TBL] [Abstract][Full Text] [Related]
47. Effects of microtubule disruption on endocytosis, membrane recycling and polarized distribution of Aquaporin-1 and gp330 in proximal tubule cells. Elkjaer ML; Birn H; Agre P; Christensen EI; Nielsen S Eur J Cell Biol; 1995 May; 67(1):57-72. PubMed ID: 7543847 [TBL] [Abstract][Full Text] [Related]
48. Monocyte chemotaxis in leukemia patients. Norris DA; Weston WL; Tubergen DG; Rose B; Odom LF J Lab Clin Med; 1980 Apr; 95(4):609-15. PubMed ID: 6965698 [TBL] [Abstract][Full Text] [Related]
49. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628 [TBL] [Abstract][Full Text] [Related]
50. OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer. Friedman SM; Thompson G; Halper JP; Knowles DM J Immunol; 1982 Feb; 128(2):935-40. PubMed ID: 6976389 [TBL] [Abstract][Full Text] [Related]
51. [Cytoskeletal structures in acute lymphoblastic and chronic lymphatic leukemia]. Schmitt-Gräff A Verh Dtsch Ges Pathol; 1983; 67():574-7. PubMed ID: 6582695 [No Abstract] [Full Text] [Related]
52. Pathomorphology of acute lymphoblastic leukaemia in childhood: convolution of lymphoblast nuclei. Pap T; Retih I; Kajtár P; Kelényi G Acta Morphol Acad Sci Hung; 1980; 28(4):407-16. PubMed ID: 6937105 [TBL] [Abstract][Full Text] [Related]
53. [Relative polysome and monosome content in human lymphocytes normally and in chronic lympholeukemia depending on the therapy]. Morozov EO; Blinov MN; Samuskevich IG; Rozanova LM Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):8-12. PubMed ID: 7413629 [No Abstract] [Full Text] [Related]
54. [Basic types and vital forms of human peripheral and PHA-stimulated lymphocytes studied in vitro]. Demin SIu Tsitologiia; 2003; 45(6):535-48. PubMed ID: 14521083 [TBL] [Abstract][Full Text] [Related]
55. Morphologic and functional alterations induced by low doses of mercuric chloride in the kidney OK cell line: ultrastructural evidence for an apoptotic mechanism of damage. Carranza-Rosales P; Said-Fernández S; Sepúlveda-Saavedra J; Cruz-Vega DE; Gandolfi AJ Toxicology; 2005 Jun; 210(2-3):111-21. PubMed ID: 15840425 [TBL] [Abstract][Full Text] [Related]
56. Responses of chronic lymphocytic leukemic lymphocytes to increasing concentrations of phytohemagglutinin during short-term culture. Amaral L; Taningco J; Choi YJ; Narasimhan P; Schreiber Z; Werthamer S Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):265-7. PubMed ID: 7107074 [TBL] [Abstract][Full Text] [Related]
57. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639 [TBL] [Abstract][Full Text] [Related]
58. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227 [TBL] [Abstract][Full Text] [Related]
59. Morphology and microfilament organization in human blood lymphocytes. Effects of substratum and mitogen exposure. Sundqvist KG; Otteskog P; Wanger L; Thorstensson R; Utter G Exp Cell Res; 1980 Dec; 130(2):327-37. PubMed ID: 6893822 [No Abstract] [Full Text] [Related]
60. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine. Balakrishnan K; Wierda WG; Keating MJ; Gandhi V Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]